BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 16846460)

  • 1. An overview of factors affecting the disposition of intramammary preparations used to treat bovine mastitis.
    Gehring R; Smith GW
    J Vet Pharmacol Ther; 2006 Aug; 29(4):237-41. PubMed ID: 16846460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling the concentration-time relationship in milk from cattle administered an intramammary drug.
    Whittem T; Whittem JH; Constable PD
    J Vet Pharmacol Ther; 2012 Oct; 35(5):460-71. PubMed ID: 22150507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination kinetics of tilmicosin following intramammary administration in lactating dairy cattle.
    Smith GW; Davis JL; Baynes RE; Yeatts JL; Barlow BM; Riviere JE
    J Am Vet Med Assoc; 2009 Jan; 234(2):245-8. PubMed ID: 19210246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue distribution of cefquinome after intramammary and "systemic" administration in the isolated perfused bovine udder.
    Ehinger AM; Schmidt H; Kietzmann M
    Vet J; 2006 Jul; 172(1):147-53. PubMed ID: 16772139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effects of systemic or intramammary antimicrobial treatment of bovine subclinical mastitis during lactation.
    Sandgren CH; Waller KP; Emanuelson U
    Vet J; 2008 Jan; 175(1):108-17. PubMed ID: 17320434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefquinome sulfate behavior after intramammary administration in healthy and infected cows.
    Zonca A; Gallo M; Locatelli C; Carli S; Moroni P; Villa R; Cagnardi P
    J Dairy Sci; 2011 Jul; 94(7):3455-61. PubMed ID: 21700031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefoperazone sodium preparation behavior after intramammary administration in healthy and infected cows.
    Cagnardi P; Villa R; Gallo M; Locatelli C; Carli S; Moroni P; Zonca A
    J Dairy Sci; 2010 Sep; 93(9):4105-10. PubMed ID: 20723685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of bovine mastitis during the dry period and development of intramammary drug formulations].
    Donev B; Dancheva L
    Vet Med Nauki; 1982; 19(4):75-82. PubMed ID: 6758318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug selection and use in mastitis: systemic vs local therapy.
    Ziv G
    J Am Vet Med Assoc; 1980 May; 176(10 Spec No):1109-15. PubMed ID: 7216882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical pharmacokinetic aspects of mastitis therapy--3: intramammary treatment.
    Ziv G
    Vet Med Small Anim Clin; 1980 Apr; 75(4):657-70. PubMed ID: 6900458
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of various forms of bovine mastitis with consideration of udder pathology and the pharmacokinetics of appropriate drugs: a review.
    du Preez JH
    J S Afr Vet Assoc; 1988 Sep; 59(3):161-7. PubMed ID: 3058977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of intramammary infusion of ceftiofur hydrochloride at drying off for treatment and prevention of bovine mastitis during the nonlactating period.
    Hallberg JW; Wachowski M; Moseley WM; Dame KJ; Meyer J; Wood SL
    Vet Ther; 2006; 7(1):35-42. PubMed ID: 16598682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dry cow treatment of beef cows on pathogenic organisms, milk somatic cell counts, and calf growth during the subsequent lactation.
    Lents CA; Wettemann RP; Paape MJ; Looper ML; Buchanan DS
    J Anim Sci; 2008 Mar; 86(3):748-55. PubMed ID: 18073291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic effect of nisin Z on subclinical mastitis in lactating cows.
    Wu J; Hu S; Cao L
    Antimicrob Agents Chemother; 2007 Sep; 51(9):3131-5. PubMed ID: 17606675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic profile of erythromycin after intramammary administration in lactating dairy cows with specific mastitis.
    Bajwa NS; Bansal BK; Srivastava AK; Ranjan R
    Vet Res Commun; 2007 Jul; 31(5):603-10. PubMed ID: 17225083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proposed intramammary infusion product guidelines.
    Miller RE
    J Am Vet Med Assoc; 1977 May; 170(10 Pt 2):1203-7. PubMed ID: 559661
    [No Abstract]   [Full Text] [Related]  

  • 17. Milk and plasma disposition of thymol following intramammary administration of a phytoceutical mastitis treatment.
    McPhee CS; Anderson KL; Yeatts JL; Mason SE; Barlow BM; Baynes RE
    J Dairy Sci; 2011 Apr; 94(4):1738-43. PubMed ID: 21426962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of induced infections as a research method.
    Newbould FH
    J Am Vet Med Assoc; 1977 May; 170(10 Pt 2):1208-9. PubMed ID: 559662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic and mammary gland disposition of enrofloxacin in healthy sheep following intramammary administration.
    López C; García JJ; Sierra M; Diez MJ; Pérez C; Sahagún AM; Fernández N
    BMC Vet Res; 2015 Apr; 11():88. PubMed ID: 25889369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of sub-clinical mastitis by intramammary antibiotics infusion during lactation (Blitz therapy) in Kenya.
    Hamir AN; Gehring W; Muhammed SI
    Bull Anim Health Prod Afr; 1979 Sep; 27(3):199-202. PubMed ID: 540177
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.